Pharma-Bio Serv (PBSV) Cash from Investing Activities (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Cash from Investing Activities of -$1.9 million for Q2 2026, down 168.21% on a QoQ basis from $2.8 million in Q1 2026, and up 41.52% year-over-year from -$1.3 million in Q2 2025.
Pharma-Bio Serv (PBSV) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.9 million for Q2 2026.
- Quarterly Cash from Investing Activities rose 41.52% year-over-year to -$1.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.7 million (up 1.77% YoY) and the FY2025 annual result came in at -$1.5 million, down 7.75% from the prior year.
- Cash from Investing Activities was -$1.9 million for Q2 2026 at Pharma-Bio Serv, down from $2.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7.3 million in Q4 2023 and bottomed at -$8.2 million in Q1 2023.
- A 5-year average of -$343625.2 and a median of -$3224.0 in 2022 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 65099.47% in 2023, while the deepest fall reached 1199309.94% in 2023.
- Pharma-Bio Serv's Cash from Investing Activities stood at -$12137.0 in 2022, then soared by 60469.54% to $7.3 million in 2023, then plunged by 97.66% to $171532.0 in 2024, then plunged by 599.42% to -$856665.0 in 2025, then slumped by 120.29% to -$1.9 million in 2026.
- Business Quant data shows PBSV's Cash from Investing Activities at -$1.9 million in Q2 2026, $2.8 million in Q1 2026, and -$856665.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.29 Bn | 24.98 Bn | 662.02 Mn | -388.71 Mn |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | 747.39 Mn |
| 3 | Healthequity | 8.43 Bn | 8.16 Bn | 256.31 Mn | -13.90 Mn |
| 4 | Hinge Health | 5.96 Bn | 5.65 Bn | 154.23 Mn | 48.08 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | -1.31 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | -56.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | -112.49 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 137.98 Mn |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - | -26,000.00 |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | -1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.89 Mn |
| Apr 30, 2026 | -1.89 Mn |
| Jan 31, 2026 | 2.77 Mn |
| Jan 31, 2026 | 2.77 Mn |
| Oct 31, 2025 | -856,665.00 |
| Oct 31, 2025 | -856,665.00 |
| Jul 31, 2025 | 1.63 Mn |
| Jul 31, 2025 | 1.63 Mn |
| Apr 30, 2025 | -3.23 Mn |
| Apr 30, 2025 | -3.23 Mn |
| Jan 31, 2025 | 988,338.00 |
| Jan 31, 2025 | 988,338.00 |
| Oct 31, 2024 | 171,532.00 |
| Oct 31, 2024 | 171,532.00 |
| Jul 31, 2024 | 3.69 Mn |
| Jul 31, 2024 | 3.69 Mn |
| Apr 30, 2024 | -458,942.00 |
| Apr 30, 2024 | -458,942.00 |
| Jan 31, 2024 | -4.76 Mn |
| Jan 31, 2024 | -4.76 Mn |